PUBLIC COMPANY
saveMerck KGaA
updated 1mo ago
community read0 votes
pipeline
2
marketed
0
phase 3
1
catalysts ytd
1
approvals ytd
1
recalls ytd
0
Pipeline(2)
pipeline depth2 products
1Phase 21Phase 3
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
Where Merck KGaA is staffing up — a leading indicator of pipeline and commercial priorities.
therapeutic areaOncology 64Women's Health 14Immunology & Inflammation 10CNS / Neuroscience 9Rare Disease 6Metabolic 3
departmentCommercial 232IT & Engineering
News
- Sanofi MS drug rejected in US gets an endorsement in Europe<figure><div><img src="https://imgproxy.divecdn.com/FBR1IQNmU9Hqatva496Zg2G8JMHsqV0UGsf4LMARqYo/g:nowe:189:144/c:1776:1003/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80OTY5MDc4Mzc…biopharma_dive · 2mo ago
- Sanofi posts upbeat sales as R&D pressure builds<figure><div><img src="https://imgproxy.divecdn.com/4sV6C1TzSj2YZ2rz0W5-EST8xmsio5JNKmZoYu-be_8/g:nowe:0:87/c:520:294/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…biopharma_dive · 2mo ago
- Sanofi defends Garijo appointment, says it is 'fully committed' to immunologySanofi’s first-quarter earnings call with the media on Thursday was an exercise in redirecting the narrative before its new CEO steps in next week. CFO François-Xavier Roger defended the compan…endpoints · 2mo ago
comments(0)
5-min edit window · permanent after that